Tuberculous Lymphadenitis in Northern Ethiopia: In a Public Health and Microbiological Perspectives
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The actual burden and causative agent of tuberculous lymphadenitis (TBLN) cases is not well known due to lack of strong surveillance system and diagnostic facilities in Ethiopia. This study was conducted to determine the prevalence of TBLN, its causative agent and risk factors for acquiring this infection. METHODS: A cross-sectional study was conducted from April to May 2012 at four main hospitals and one diagnostic clinic located in northern Ethiopia. Fine needle aspirates (FNAs) from TBLN suspects were taken for acid fast bacilli (AFB) microscopy, culture and molecular typing. RESULTS: Among 437 aspirates, culture yielded AFB in 226 (51.7%) of cases. Sixty one culture negative cases (30.5% of 200 cases) were positive by Xpert MTB/RIF test. Moreover, a rifampicin resistant AFB was detected from culture negative cases. The overall prevalence of FNAs positive TBLN cases was 65.8 %. The BacT/AlerT 3D system proved to be a more rapid method with higher recovery rate than Lowenstein-Jensen (L-J) and/or Gottsacker media (P<0.0001). Molecular typing identified all culture positive isolates as M.tuberculosis. The main risk factors for TBLN were pediatric age (OR 2.8, 95% CI, 1.09- 7.05) and cough (OR 2, 95%CI, 1.09-3.7). CONCLUSIONS: The results of this study revealed a high prevalence of TBLN in the study sites and that pediatric age and cough are key predictors of the disease. TBLN is an important public health problem that needs to be addressed in the area. It is important to note that MDR strains of TB could be involved and aetiological confirmation and drug sensitivity testing of TBLN isolates should be expanded. Further studies on the M.tuberculosis lineages, circulating strains and transmission dynamics, are recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sharma, S. K., Mohan, A., & Kohli, M. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1927718 · Cited by 441
Fine needle aspiration cytology of suspected tuberculous lymphadenitis
Bezabih, M., Mariam, D. W., & Selassie, S. G. (2002) · Cytopathology · doi:10.1046/j.1365-2303.2002.00418.x · Cited by 149
Identification of the Causative Organism of Tuberculous Lymphadenitis in Ethiopia by PCR
Kidane, D., Olobo, J. O., Habte, A., Negesse, Y., Aseffa, A., Abate, G., Yassin, M. A., Bereda, K., & Harboe, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4230-4234.2002 · Cited by 126 · cited 1×
“bovis have been reported as the most frequent causative agents in TBLN [5-8].”
BackgroundAssessment of possible tuberculous lymphadenopathy by PCR compared to non-molecular methods
Pahwa, R., Hedau, S., Jain, S., Jain, N., Arora, V. M., Kumar, N., & Das, B. C. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45904-0 · Cited by 76 · cited 1×
“7), a finding similar to other authors [14,18,19].”
ResultDerese, Y., Hailu, E., Assefa, T., Bekele, Y., Mihret, A., Aseffa, A., Hussien, J., Ali, I., & Abebe, M. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2050 · Cited by 61
Annam, V., Karigoudar, M., & Yelikar, B. (2009) · Indian Journal of Pathology and Microbiology · doi:10.4103/0377-4929.54991 · Cited by 39
Dot-ELISA vs. PCR of Fine Needle Aspirates of Tuberculous Lymphadenitis
Jain, A., Verma, R. K., Tiwari, V., & Goel, M. M. (2005) · Acta Cytologica · doi:10.1159/000326089 · Cited by 16
Cited by
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015) · Medicine · doi:10.1097/md.0000000000000509 · Cited by 43
Fantahun, M., Kebede, A., Yenew, B., Gemechu, T., Mamuye, Y., Tadesse, M., Brhane, B., Jibriel, A., Solomon, D., & Yaregal, Z. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222402 · Cited by 38
“The prevalence of culture confirmed TBLN is also reported above 50% [3, 4].”
BackgroundSarfaraz, S., Iftikhar, S., Memon, Y., Zahir, N., Hereker, F. F., & Salahuddin, N. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.020 · Cited by 35
Metadata
- Authors
- Biadglegne, F., Tesfaye, W., Sack, U., & Rodloff, A. C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-09
- Volume
- 8
- Issue
- 12
- Pages
- e81918
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2045196373
- Cited by
- 35
- References
- 7
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tuberculous Lymphadenitis in Northern Ethiopia: In a Public Health and Microbiological Perspectives. https://app.cochat.ai/papers/10.1371/journal.pone.0081918
- The paper
- Biadglegne, F., Tesfaye, W., Sack, U., & Rodloff, A. C. (2013). Tuberculous Lymphadenitis in Northern Ethiopia: In a Public Health and Microbiological Perspectives. PLoS ONE. https://doi.org/10.1371/journal.pone.0081918
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.